์ข…์–‘์€ 3๊ฐ€์ง€๋กœ ๋ถ„๋ฅ˜ํ•  ์ˆ˜ ์žˆ๋‹ค.

  • Mesenchymal (๊ฐ„์งˆ์„ธํฌ ์œ ๋ž˜) : ์ค‘๋ฐฐ์—ฝ ์œ ๋ž˜, ๊ฒฐํ•ฉ์กฐ์ง/ํ˜ˆ๊ด€/๊ทผ์œก/์—ฐ๊ณจ/๋ผˆ ๋“ฑ. ๋ฌด์กฐ๊ฑด ์•…์„ฑ์ž„.
  • Epithelial (์ƒํ”ผ์„ธํฌ ์œ ๋ž˜) : ์™ธ/์ค‘/๋‚ด๋ฐฐ์—ฝ ์œ ๋ž˜. adenoma/adenocarcinoma, papilloma/carcinoma
  • Round cell (๋ฉด์—ญ์„ธํฌ ์œ ๋ž˜) : mesenchymal์— ํ•ด๋‹นํ•˜์ง€๋งŒ ๋”ฐ๋กœ ๋ถ„๋ฅ˜.

1. Overview of Round Cell Tumors in Dogs

  • ๋Œ€๋ถ€๋ถ„ ๋ฉด์—ญ์„ธํฌ ์œ ๋ž˜๋‹ค. (hematopoietic or dendritic lineages)
  • ํ”ํ•œ ์ข…๋ฅ˜ : Histiocytoma, Lymphoma, Plasmacytoma, Mast Cell Tumor, TVT
  • ๋‹ค๋“ค ๋™๊ธ€๋™๊ธ€ํ•˜๊ฒŒ ์ƒ๊ฒจ์„œ ๊ตฌ๋ถ„์ด ์–ด๋ ต๋‹ค.


Morphological features of Immune cells(ํ•„๊ธฐ from ๋ณ‘๋ฆฌ1).

  • -phil๋กœ ๋๋‚˜๋Š” ๋ฉด์—ญ์„ธํฌ๋“ค์€ ์ข…์–‘์„ธํฌ๊ฐ€ ๋˜์ง€ ์•Š๋Š”๋‹ค. (Neutrophil, Basophil, Eosinophil)
    • ๋ถ„์ ˆํ™”๋œ ํ•ต์„ ๊ฐ€์ง„๋‹ค. (๋ถ„์ ˆํ™”๋œ ์ •๋„ โ‡’ ์„ธํฌ์˜ ๋‹จ๊ณ„ ๊ตฌ๋ถ„์— ๋„์›€)
    • ์ด๋Ÿฐ ์„ธํฌ๊ฐ€ ๋งŽ์œผ๋ฉด ์—ผ์ฆ์„ฑ ์งˆํ™˜ ์˜์‹ฌ, ํ˜น์€ ๊ณจ์ˆ˜ ์ชฝ ์งˆํ™˜ (leukemia ๋“ฑ)
    • ์šฐ๋ฆฌ๊ฐ€ ์ƒ๊ฐํ•˜๋Š” ๋ฉ์–ด๋ฆฌ์ง„ ์ข…์–‘์„ ํ˜•์„ฑํ•˜๋Š” ์„ธํฌ๋“ค์€ ์•„๋‹ˆ๋‹ค!
  • ๋‚˜๋จธ์ง€๋Š” ๋‹ค ์ข…์–‘์ด ๋  ์ˆ˜ ์žˆ๋‹ค. (Mast cell, Lymphocytes, Plasma cell, Macrophage, ..)


Morphological features of Immune cells(ํ•„๊ธฐ from ๋ณ‘๋ฆฌ1).

-phils ๋“ค์€ ์ข…์–‘์ด ๋˜์ง€ ์•Š๊ณ , ๋‚˜๋จธ์ง€ ์„ธํฌ๋“ค ๊ตฌ๋ถ„ํ•˜๊ธฐ!

  • Plasma cells : ์น˜์šฐ์นœ ํ•ต + ํ•ต ์˜†์— ๋ฐ๊ฒŒ ๋น›๋‚˜๋Š” ๋ถ€๋ถ„ + ํ•ต์˜ ๊ณผ์—ผ์ƒ‰์„ฑ(๋งค์šฐ ์ง„ํ•จ)
  • Macrophages : ํ•ต๋„ ํฌ๊ณ  ์„ธํฌ๋„ ํฌ๋‹ค. ์„ธํฌ์งˆ์˜ ํ’๋ถ€ํ•œ ๊ณตํฌ + ํ•ต์ด ๋™๊ทธ๋ž—๊ธฐ๋ณด๋‹จ ์ฝฉ ๋ชจ์–‘ + variation โ†‘
  • Mast cells : ๋ณด๋ผ์ƒ‰์˜ ํ˜ธ์—ผ์„ฑ ๊ณผ๋ฆฝ๋“ค์ด ์—„์ฒญ ๋งŽ์ด ๊ด€์ฐฐ๋œ๋‹ค. (์‹ค์ œ๋กœ๋Š” ํ˜ธ์‚ฐ์„ฑ์œผ๋กœ ๋ณด์ด๊ธฐ๋„ ํ•œ๋‹ค)
  • Lymphocytes : ํ•ต์˜ ๋น„์ค‘์ด ํ›จ์”ฌ ๋†’๋‹ค.
  • Epithelioid macrophages, multinucleated giant macrophages : ์œก์•„์ข…์„ฑ ์—ผ์ฆ์—์„œ ๋” ์ค‘์š”ํ•œ ์ง€ํ‘œ์ด์ง€๋งŒ, histiocytoma(์•…์„ฑ)์—์„œ๋„ ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ๋‹ค.

2. Canine Cutaneous Histiocytoma

  • ์ž์—ฐ์ ์œผ๋กœ ํ‡ดํ–‰ ๊ฐ€๋Šฅ, ๊ฐ€์žฅ ์•ˆ์ „ํ•œ ์ข…์–‘
  • ๊ธฐ์› : ํ”ผ๋ถ€์— ์ •์ƒ์ ์œผ๋กœ ์กด์žฌํ•˜๋Š” Langerhans cells
  • ์–ด๋ฆฐ ๊ฐœ์—์„œ ๋‚˜ํƒ€๋‚จ (<4 years) /

Histology of Histiocytoma

  • dense dermal infiltrates : ์ง„ํ”ผ์ธต์— ๊ตญํ•œ๋˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Œ.
  • pleomorphism : histiocytoma์˜ ๊ธฐ๋ณธ ํŠน์ง•. ๋ณด์ธ๋‹ค๊ณ  ๋ฌด์กฐ๊ฑด ์•…์„ฑ๋„๊ฐ€ ๋†’๋‹ค๊ณ  X
  • minimal stroma : ์ง„ํ”ผ์ธต์— ์ข…์–‘์ด ์ž๋ผ, ์ง„ํ”ผ์ธต์— ์žˆ์–ด์•ผ ํ•  ๊ฒƒ๋“ค์ด ์‚ฌ๋ผ์ง. (์ฝœ๋ผ๊ฒ์ด ์‹น ์‚ฌ๋ผ์ง)
  • wedge-shaped : ํ™•์ง„์˜ ์ค‘์š”ํ•œ ๊ธฐ์ค€ ์ค‘ ํ•˜๋‚˜.
  • ์ข…์–‘์„ธํฌ๊ฐ€ ํ‘œํ”ผ์— ๋ถ™์–ด์„œ ์ž๋ž€๋‹ค๋Š” ํŠน์ง•์ด ์žˆ๋‹ค. (์ค‘์š”ํ•œ ๊ตฌ๋ณ„์  ์ค‘ ํ•˜๋‚˜)

round cell tumor ์ค‘์—์„œ ๊ฐ๋ณ„์ง„๋‹จ ํ•˜๊ธฐ ์ด์ „์— round cell tumor๋ผ๋Š” ๊ฒƒ์„ํ™•์ธ ์—ผ์ฆ๊ณผ ๊ฐ๋ณ„ ํ•„์š”.

์—ผ์ฆ์€

  • ?
  • ์ข€ ๋” heterogenous(์—ฌ๋Ÿฌ ์„ธํฌ๊ฐ€ ๋’ค์„ž์—ฌ ์žˆ์Œ), Round cell tumor๋Š”
  • ๋น„๊ต์  ํ•œ ์ข…๋ฅ˜์˜ round cell๋กœ ๊ฝ‰ ์ฐจ ์žˆ๋‹ค.

2-1. Canine Cutaneous Histiocytoma vs. Epitheliotropic Lymphoma

Canine Histiocytoma์™€ ๋น„์Šทํ•œ ์กฐ์งํ•™์  ์†Œ๊ฒฌ์„ ๋ณด์ด๋Š” ์ข…์–‘์œผ๋กœ, ๋‘ ์ข…์–‘์˜ ์˜ˆํ›„๋Š” ์™„์ „ํžˆ ๋‹ค๋ฅด๊ธฐ ๋•Œ๋ฌธ์— ์„ธ๋ฐ€ํ•œ ๊ตฌ๋ถ„์ด ํ•„์š”ํ•˜๋‹ค.

Cutaneous histiocytomaEpitheliotropic lymphoma
์ข…์–‘์„ธํฌ๊ฐ€ ํ‘œํ”ผ ์„ ์„ ๋”ฐ๋ผ ๋ฐฐ์—ด๋˜์–ด ์žˆ๋‹ค.์ข…์–‘์„ธํฌ๊ฐ€ ํ‘œํ”ผ ์„ ๊ณผ ๋–จ์–ด์ ธ ์žˆ๋‹ค.
collagen์ด ๊ฑฐ์˜ ์—†๋‹ค.์‚ฌ์ด์‚ฌ์ด collagen์ด ๋งŽ์ด ๋ณด์ธ๋‹ค.
์ง„ํ”ผ์ธต์—๋งŒ ๊ตญํ•œ๋˜์–ด ์ž๋ž€๋‹ค.ํ‘œํ”ผ์นจ์Šต์„ฑ์„ ๊ฐ€์ง„๋‹ค.

Round cell tumor๋Š” type์— ๋”ฐ๋ผ ์˜ˆํ›„๊ฐ€ ๋‹ค๋ฅด๋‹ค. ์ง„๋‹จ๋ช…์— ๋”ฐ๋ผ ์˜ˆํ›„๊ฐ€ ์™„์ „ํžˆ ๋‹ค๋ฅด๊ธฐ ๋•Œ๋ฌธ์— ๊ตฌ๋ถ„์„ ์ž˜ํ•ด์•ผ ํ•œ๋‹ค.

์–ด๋–ค round cell tumor์—ฌ๋„ ์ข…์ฐฉ์ ์€ IHC (๋ฉด์—ญ์—ผ์ƒ‰) ์ด๋‹ค. Round cell tumor ๊ตฌ๋ถ„์„ ์œ„ํ•ด ๋ฉด์—ญ์—ผ์ƒ‰ ํ•„์ˆ˜! ์™ธ์šฐ๋Š” ๊ฒŒ ์ข‹์ง€!

  • CD1a+, CD18+, CD11c+, MHC โ…ก+, E-cadherin+ (histiocyte ์œ ๋ž˜์ž„์„ ํ™•์ธํ•  ์ˆ˜ ์žˆ๋Š” ๋งˆ์ปค. ์‚ฌ๋žŒ๋งˆ๋‹ค ์„ ํ˜ธ๊ฐ€ ๋‹ค๋ฆ„.)
  • Thy-1-, CD4- (๋‹ค๋ฅธ ๋งˆ์ปค์— ๋Œ€ํ•ด ์Œ์„ฑ์ž„์„ ํ™•์ธํ•ด์•ผ ํ™•์ง„ ๊ฐ€๋Šฅ)
  • No Birbeck granules (EM)

histiocyte ํ™•์ธ ๋งˆ์ปค, lymphoma ํ™•์ธ ๋งˆ์ปค.. ์ด๋Ÿฐ ์ข…๋ฅ˜๋ณ„ ๋งˆ์ปค๋ฅผ ํŒจ๋„๋กœ ๊ฒ€์‚ฌํ•จ. ๋‹ค๋ฅธ ๋งˆ์ปค๋“ค์€ ์Œ์„ฑ์ธ์ง€๋„ ๊ฐ™์ด ํ™•์ธํ•ด์•ผ ํ•จ. ๋ฉด์—ญ์—ผ์ƒ‰์€ ์œ ๋ž˜๋ฅผ ์ฐพ์„ ๋•Œ๋งŒ ์“ด๋‹ค. Histiocyte ์œ ๋ž˜์ž„์„ ํ™•์ธํ•˜๋Š” ๊ฒƒ์ด์ง€, histiocytoma์ธ์ง€ histiocytic sarcoma์ธ์ง€ ๊ตฌ๋ถ„ํ•ด์ฃผ์ง€ ์•Š๋Š”๋‹ค. ์–‘์„ฑ์ธ์ง€ ์•…์„ฑ์ธ์ง€๋Š” H&E๋กœ ํ™•์ธ.

Cutaneous Lymphoma

  • T ๋˜๋Š” B lymphocytes์—์„œ ์œ ๋ž˜ํ•œ ์ข…์–‘์ด๋‹ค.
  • T cell ์œ ๋ž˜์˜ ๊ฒฝ์šฐ ํ‘œํ”ผ์— ๋ฐ”์ง ๋ถ™์–ด์„œ, microabscesses(์•„์ฃผ์ž‘์€ ๋†์–‘)์„ ํ˜•์„ฑํ•˜๋Š” ๋ณ‘๋ณ€์„ ๋ณด์ธ๋‹ค. ํ‘œํ”ผ์— ๋ฐ”์ง ๋ถ™๊ณ , ํ‘œํ”ผ์— ์นจ์Šตํ•˜๋Š” ๊ฒฝํ–ฅ์„ฑ์„ ๋ณด์ธ๋‹ค.
  • ๋น„์ •ํ˜•์„ฑ์ด ๋†’๋‹ค(high-grade atypia), ์ฆ‰ ์ œ๋ฉ‹๋Œ€๋กœ ์ƒ๊ธด ํŽธ์ด๋‹ค. ๊ทธ๋ž˜์„œ ๋‹ค๋ฅธ ๊ณ„์—ด๊ณผ ํ—ท๊ฐˆ๋ฆฌ๊ธฐ ์‰ฝ๋‹ค.
  • ํ™•์ง„์„ ์œ„ํ•œ ๋ฉด์—ญ์—ผ์ƒ‰
    • T cell ์œ ๋ž˜ ํ™•์ธ : CD3+
    • B cell ์œ ๋ž˜ ํ™•์ธ : CD79a+

Plasmacytoma

  • B cell์—์„œ ๋ถ„ํ™”ํ•œ plasma cell์—์„œ ์œ ๋ž˜ํ•œ ์ข…์–‘์ด๋‹ค.
  • ์‚ฌ์ง€์˜ ํ”ผ๋ถ€, ๊ตฌ๊ฐ• (limbs, oral clavity) ์—์„œ ํ˜ธ๋ฐœํ•œ๋‹ค.
    • ๊ตฌ๊ฐ•์— ์ƒ๊ธฐ๋ฉด oral plasmacytoma
  • Plasma cell์€ ํ˜•ํƒœ์  ํŠน์ง•์ด ๋šœ๋ ทํ•œ ํŽธ: ํ•ต์ด ํ•œ์ชฝ์— ์น˜์šฐ์ณ ์žˆ๊ณ , ์„ธํฌ์งˆ์˜ ์—ผ์ƒ‰์„ฑ์ด ์ง„ํ•˜๋‹ค.
  • ๊ทธ๋ž˜๋„ ํ™•์ง„์„ ์œ„ํ•ด์„œ๋Š” ๋ฉด์—ญ์—ผ์ƒ‰์ด ํ•„์š”ํ•˜๋‹ค : CD79a+, MUM1+
    • CD79a๋Š” B cell๊ณผ plasma cell์— ๋‘˜ ๋‹ค ๋ฐ˜์‘ํ•จ
    • MUM1์€ plasma cell์— ํŠน์ด์ ์œผ๋กœ ๋ฐ˜์‘ (์š”์ฆ˜ ๋” ์„ ํ˜ธ๋จ)

Mast Cell Tumor

  • Dermal mast cells์—์„œ ์œ ๋ž˜ํ•œ ์ข…์–‘์ด๋‹ค.
  • Mast cell์€ ์„ธํฌ์งˆ ์•ˆ์— ํ˜ธ์—ผ์„ฑ ๊ณผ๋ฆฝ์„ ๋งŽ์ด ๊ฐ€์ง„๋‹ค.
    • ํ•˜์ง€๋งŒ eosinophilic/basophilic ๊ณผ๋ฆฝ์ด ๋‘˜ ๋‹ค ๊ด€์ฐฐ๋˜๋Š” ํŽธ์ด๋‹ค.
    • ํ˜ธ์—ผ์„ฑ์ธ์ง€ ํ˜ธ์‚ฐ์„ฑ์ธ์ง€๋ณด๋‹ค๋Š”, ์„ธํฌ์งˆ ์ž์ฒด๊ฐ€ ๊ณผ๋ฆฝ ์–‘์ƒ์ธ์ง€ ์•„๋‹Œ์ง€๊ฐ€ ์ค‘์š”ํ•˜๋‹ค.
  • ํ™•์‹ ์„ ์œ„ํ•ด์„œ๋Š” ๋ฉด์—ญ์—ผ์ƒ‰์ด ํ•„์š”ํ•˜๋‹ค : c-Kit (CD117)+, tryptase+
    • c-Kit์€ ์•„์ฃผ ์œ ๋ช…ํ•œ mast cell ๋งˆ์ปค~

Transmissible Venereal Tumor (TVT)

  • ๊ฐ€์žฅ ๋ณด๊ธฐ ์–ด๋ ต๋‹ค.
  • Histiocyte ๊ณ„์—ด์—์„œ ์œ ๋ž˜ํ•œ ์ข…์–‘์ด๋‹ค.
  • ์™ธ๋ถ€ ์ƒ์‹๊ธฐ, ๊ตฌ๊ฐ•์—์„œ ํ˜ธ๋ฐœํ•œ๋‹ค.
  • cytoplasm์˜ ๊ณตํฌํ™”: histiocyte ๊ณ„์—ด์˜ ๊ณตํ†ต์ ์ด๋‹ค.
  • ๋ฉด์—ญ ์—ผ์ƒ‰ ๋งˆ์ปค : MHC โ…ก+, vimentin+ (histiocytoma ๋งˆ์ปค์™€ ๋‹ค๋ฅด์ง€ ์•Š๋‹ค.)
  • ๋‹ค๋งŒ histiocytoma์™€ ๋‹ฌ๋ฆฌ, ํƒ€์•ก์„ ํ†ตํ•œ ์ „์—ผ์„ฑ์ด ์žˆ๋‹ค.
  • ์–‘์„ฑ์ธ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ๋‹ค. ์•…์„ฑ์ผ ๊ฒฝ์šฐ๋Š” ๋“œ๋ฌผ์ง€๋งŒ ์žˆ๋‹ค.
    • Cutaneous histiocytoma๋Š” ๋ฌด์กฐ๊ฑด ์–‘์„ฑ์ธ๋ฐ, TVT๋Š” ์ข…์ข… ์•…์„ฑ์ผ ์ˆ˜๋„ ์žˆ๋‹ค.

Pasted image 20260515004833.jpg

Canine and Feline Mast Cell Tumors

์ฃผ๋กœ Low-graded์™€ high-graded๋กœ ๋‚˜๋ˆˆ๋‹ค. โ‡’ ์ž„์ƒ์ ์œผ๋กœ๋„ ๋ฐ€์ ‘ํ•œ ๊ด€๋ จ.

๋ณ‘๋ฆฌ์  ํŒ๋‹จ ๊ธฐ์ค€๊ณผ ์˜ˆํ›„๊ฐ€ ๊ฐ€์žฅ ์•ˆ ๋งž๋Š” ์ข…์–‘ ์ค‘ ํ•˜๋‚˜.

In Dogs

  • ๋ฐœ์ƒ๋ฅ ์ด ๋†’๋‹ค.
  • ์•„์ฃผ ์–‘์„ฑ์—์„œ ์•„์ฃผ ์•…์„ฑ๊นŒ์ง€ ๋‹ค ๊ฐ€๋Šฅํ•ด์„œ, ์˜ˆํ›„ ํŒ๋‹จ์— ์กฐ์งํ•™์  grading์— ์˜์กดํ•˜์ง€๋งŒ, ๊ทธ grading์กฐ์ฐจ๋„ ์ž˜ ์•ˆ ๋งž์•„๋–จ์–ด์ง€๋Š” ๋ถ€๋ถ„์ด ์žˆ์Œ.
  • OPWG(Oncology-Pathology Working Group) ์—์„œ grading ๊ธฐ์ค€๊ณผ ์˜ˆํ›„๋ฅผ ์—ฐ๊ฒฐ์‹œํ‚ฌ ๊ฒƒ์ธ์ง€ ๊ณ„์† ์—ฐ๊ตฌ ์ค‘.

[ Criteria ]

  • 3-Tier : ์ฒ˜์Œ์— โ…  - โ…ก - โ…ข ์œผ๋กœ ๋‚˜๋ˆ„์—ˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ์• ๋งคํ•˜๊ณ , ๊ฐ™์€ โ…ก ์•ˆ์—์„œ ์˜ˆํ›„๊ฐ€ ๋„ˆ๋ฌด ์ œ๊ฐ๊ฐ.
    • ๊ธฐ์ค€ : ์„ธํฌ์˜ ๋ชจ์–‘, ์นจ์Šต์ ์ธ์ง€, ๋ถ„์—ด ์†๋„, ๊ดด์‚ฌ
  • 2-Tier : Low & High๋กœ ๋‚˜๋ˆ„์—ˆ๋‹ค.
    • ๊ธฐ์ค€ : ๋ถ„์—ด ์†๋„, ๋น„์ •์ƒ์ ์ธ ํ•ต, ํ•ต์ด ์—ฌ๋Ÿฌ ๊ฐœ, ํ•ต์ด ์ปค์ ธ ์žˆ๋Š” ๊ฒƒ โ‡’ ์„ธํฌ์˜ ๋ชจ์–‘๋งŒ ๋ณด๊ณ  ๊ฒฐ์ •ํ•˜๋ฏ€๋กœ ๋ถ€์ ์ ˆํ•˜๋‹ค.

๊ทธ๋ž˜์„œ ์š”์ฆ˜์€ ๋‘˜ ๋‹ค ์“ด๋‹ค.

  • Grade โ…  / Low
  • Grade โ…ก / Low or High
  • Grade โ…ข / High ์ด ๊ธฐ์ค€์ด ์ง€๊ธˆ์œผ๋กœ์„œ๋Š” ์ตœ์„ . ์˜ˆํ›„๋ฅผ ํŒ๋‹จํ•  ์ˆ˜ ์žˆ๋Š” ํ˜„์žฌ๋กœ์„œ๋Š” ์œ ์ผ๋ฌด์ดํ•œ ๊ธฐ์ค€์ด์ง€๋งŒ, ๋ฐ˜๋“œ์‹œ ์ž˜ ๋“ค์–ด๋งž์ง€๋Š” ์•Š๋Š”๋‹ค.

๊ทธ๋Ÿผ ๋งŽ๋‹ค/์ ๋‹ค๋ฅผ ํŒ๋‹จํ•˜๋Š” ๊ธฐ์ค€์€?

  • Mitotic Count (MC) : ์œ ์‚ฌ๋ถ„์—ด์ƒ์˜ ๋งŽ๊ณ ์ ์Œ์„ ํŒ๋‹จํ•˜๋Š” ๊ธฐ์ค€
    • 10 HPF @ ร—40 (10๊ฐœ / 40๋ฐฐ ์‹œ์•ผ), ํ•œ ์‹œ์•ผ๋Š” 2.37mm2 ๊ธฐ์ค€
    • MC > 5 โ†’ MST (ํ‰๊ท ์ƒ์กด๊ธฐ๊ฐ„) = 2~5๊ฐœ์›”
    • MC โ‰ค 5 โ†’ MST = 70๊ฐœ์›”
    • ํ•œ ๊ฐœ ์ฐจ์ด๋กœ ๊ทน๋ช…ํ•˜๊ฒŒ ๊ฐˆ๋ฆฌ๊ธฐ ๋•Œ๋ฌธ์— ์œ ์‚ฌ๋ถ„์—ด์ƒ์„ ์ •ํ™•ํžˆ ์…€ ์ค„ ์•Œ์•„์•ผ ํ•œ๋‹ค.

High MC๋Š” ์ „์ด(metastasis)์™€๋Š” ์ƒ๊ด€์ด ์žˆ์ง€๋งŒ, ์žฌ๋ฐœ(recurrence)๊ณผ๋Š” ์ƒ๊ด€์ด ์—†๋‹ค. ํ•ต์˜ ํ˜•ํƒœ๋Š” ์ƒ๊ด€์„ฑ์ด ๋†’๋‹ค.

  • Cytological Grading (Camus Criteria) : ์„ธํฌ

    • ๊ณผ๋ฆฝ ์–‘์ƒ์ด ์—†๊ฑฐ๋‚˜, ์•„๋ž˜ ์ค‘ 2๊ฐ€์ง€ ๋งŒ์กฑ (granulation์ด ์—†์–ด์•ผ ํ•œ๋‹ค?)
    • ์„ธํฌ์งˆ์˜ ํ˜•ํƒœ์™€ ํ•ต์˜ ํ˜•ํƒœ๋Š” ์ƒ๊ด€์„ฑ์ด ๋†’๋‹ค. ์„ธํฌ์งˆ์— ๊ณผ๋ฆฝ์ด ์žˆ๋Š”์ง€ ์—†๋Š”์ง€ โ†’ ํ•ต์ด ์–ด๋–ค์ง€ ์ˆœ์„œ๋กœ ๋ณด๋ฉด high grade๋ฅผ ํŒ๋‹จํ•˜๊ธฐ ์ข‹๋‹ค.
    • ํ•œ๊ณ„์  : High grade๋ฅผ ์ง„๋‹จํ•˜๊ธฐ ์ข‹์ง€๋งŒ, ์นจ์Šต ์—ฌ๋ถ€๋‚˜ ์กฐ์ง์˜ ์ „๋ฐ˜์ ์ธ ๋ชจ์–‘์„ ๋ณด์ง€๋Š” ์•Š๋Š”๋‹ค.
  • OPWG Recommendation (์ „๋ฌธ๊ฐ€๋“ค๋ผ๋ฆฌ ์ •ํ•œ ๊ฒƒ~)

    • 3-Tier์™€ 2-Tier ์ข…ํ•ฉ์ ์œผ๋กœ ์‚ฌ์šฉํ•˜๊ธฐ๋กœ
    • ๋‚˜์ด, ์ข…์–‘์ด ์–ผ๋งˆ๋‚˜ ํฐ์ง€, ์œ„์น˜, ์ ˆ์ œ๊ฐ€ ์ž˜ ๋˜์—ˆ๋Š”์ง€, ์นจ์Šต์ ์ด์ง€ ์•Š์€์ง€ ๋‹ค ๊ณ ๋ คํ•ด์„œ grading
    • ๋„๋ง(cytology)์„ ํ†ตํ•ด screening์„ ํ•  ์ˆ˜ ์žˆ๋‹ค (๋„๋ง๋กœ MCT ์˜์‹ฌ ๋จผ์ € โ†’ ์กฐ์ง๊ฒ€์‚ฌ)

In Dogs

  • MCT : ๊ณ ์–‘์ด ํ”ผ๋ถ€์ข…์–‘์˜ ๊ฑฐ์˜ 20%
  • ๊ณ ์–‘์ด์—์„œ๋Š” ์–‘์„ฑ์ธ ๊ฒฝ์šฐ๊ฐ€ ์ข€ ๋” ๋งŽ์ง€๋งŒ, 1/5 ์ •๋„(22%)๋Š” ์•…์„ฑ์œผ๋กœ ์ง„ํ–‰.

์—ฐ๊ตฌ

  • Group 1 : 1000์ผ์ด์ƒ ์ƒ์กด

๊ณ ์–‘์ด์˜ ๊ฒฝ์šฐ๋Š” tumor size๊ฐ€ ์ค‘์š”ํ•˜๋‹ค. Tumor diameter > 1.5cm ์ด๋ฉด ์•…์„ฑ behavior๋ฅผ ๋ณด์ผ ํ™•๋ฅ ์ด ๋†’๋‹ค.

์ฐธ๊ณ ์‚ผใ…‡๋งˆ์„œ,, ์ฝ์–ด๋ณด์„ธ์š”..

  • High grade :

    • 1000์ผ ์ „์— ๊ฑฐ์˜ ์‚ฌ๋ง (Low grade : ์ƒ์กด๋ฅ ์— ๊ฑฐ์˜ ์˜ํ–ฅ์„ ์ฃผ์ง€ ์•Š์Œ)
    • Splenic MCT : ๋น„์žฅ์—์„œ ๊ด€์ฐฐ๋œ ๊ฒฝ์šฐ๊ฐ€ 60% (high-grade group์€ ๋ณต๊ฐ• ์žฅ๊ธฐ๋กœ ์ „์ด๋œ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์•˜๋‹ค)
  • agressive behavior ์˜ˆ์ธก ์ธ์ž (์ƒ๊ด€์„ฑ์ด ๋†’์•˜๋˜ ๊ฒƒ๋“ค)

    • Subcutaneous invasion
    • Pyknosis/karyorrhexis
    • Neoplastic emboli
    • Lymphoid aggregates

16, 19์˜ ์ง„๋‹จ๋ช…์€ ๊ฐ™๋‹ค

๋น„์žฅ histiocytoma๋Š” ๋ฐฐ์ œ

  • lymphoma
  • mast cell tumor

  • ๋ฆผํ”„์ ˆ ํ™•์ธ : capsulation, ์ฃผ๋ณ€์˜ ์ง€๋ฐฉ์กฐ์ง (์œ„์น˜์ƒ ๋ฆผํ”„์ ˆ์ด์—ˆ์–ด๋„ ํ‹€๋ฆด ์ˆ˜ ์žˆ์Œ)
    • Lymphoid follicle, ์ค‘์‹ฌ๋ถ€์˜ germinal center, ํ”ผ์งˆ๊ณผ ์ˆ˜์งˆ
    • ์ด ์‚ฌ์ง„์€ ์ •์ƒ ๊ตฌ์กฐ๋ฅผ ์ „ํ˜€ ๊ด€์ฐฐํ•  ์ˆ˜ ์—†๊ณ  ๋ฌด์–ธ๊ฐ€๋กœ ๊ฝ‰ ์ฐจ์žˆ์Œ.
    • ๊ฒฐํ•ฉ์กฐ์ง์œผ๋กœ๋งŒ ๋‘˜๋Ÿฌ์‹ธ์—ฌ์•ผ ํ•˜๋Š”๋ฐ, ์•ˆ์ชฝ์˜ ์ข…์–‘์„ธํฌ์™€ ๊ฐ™์€ ์ข…๋ฅ˜์˜ ์–ด๋–ค ์„ธํฌ๊ฐ€ ๊ฒฐํ•ฉ์กฐ์ง ์‚ฌ์ด์— ์žˆ์Œ: ์ข…์–‘์„ธํฌ๊ฐ€ ๊ฒฐํ•ฉ์กฐ์ง์— ์นจ์Šตํ•จ.

16, 19

  • ๋น„์žฅ์—์„œ lymphoma๊ฐ€ ๋งŽ์ด ์ƒ๊ธด๋‹ค.
  • white pulp ์˜ ์ข…์–‘์„ฑ ๋ณ‘๋ณ€ โ†’ red pulp ์œ„์ถ• โ†’ ํšŒ๋ฐฑ์ƒ‰์œผ๋กœ ๋ณด์ž„ (Red pup ์œ ๋ž˜ ์ข…์–‘ ๋ณ‘๋ณ€์ด๋ฉด ์ข€ ๋” ๋ถ‰์€์ƒ‰)
  • ์กฐํ˜ˆ์ž‘์šฉ์ด ํ™œ๋ฐœํ•œ ์žฅ๊ธฐ์—ฌ์„œ ์ถœํ˜ˆ, ํŒŒ์—ด์ด ์ž˜ ์ƒ๊ธธ ์ˆ˜ ์žˆ๋‹ค.
  • ์„ธํฌ๊ด€์ฐฐ : round cell ์ข…๋ฅ˜ ๊ตฌ๋ถ„ํ•˜๋ ค๋ฉด, ์ผ๋‹จ ํ™•์‹คํ•œ ๋ฐฉ๋ฒ•์€ CD3, CD20 ๋“ฑ ๋ฉด์—ญ์—ผ์ƒ‰. ํ˜•ํƒœํ•™์ ์œผ๋กœ ๊ตฌ๋ถ„์ด ์ •ํ™•ํ•˜์ง„ ์•Š์ง€๋งŒ, ๋ฐฐ์ œํ•˜๋ฉด์„œ ๊ฐ€์•ผ ํ•จ
    • plasmacytoma โ†’ ๋น„์žฅ์— ์•ˆ ์ƒ๊น€. ๋น„์žฅ์— ์ƒ๊ธฐ๋ฉด multiple myeloma. ํ˜•ํƒœํ•™์ ์œผ๋กœ๋„ ํŽธ์ธก์„ฑ์˜ ํ•ต์ด๋‚˜, ์—ผ์ƒ‰์„ฑ์ด ์ง„ํ•œ ์„ธํฌ์งˆ์ด๋‚˜ ํ•ต ์•„๋‹˜.
    • Mast cell โ†’ ์•„์ฃผ ๋ฐฐ์ œํ•  ์ˆœ ์—†์Œ. ๊ฐ๋ณ„์ง„๋‹จ ๋“ค์–ด๊ฐˆ ์ˆ˜๋„ ์žˆ์ง€๋งŒ, ๊ณผ๋ฆฝ ์–‘์ƒ์„ ๋ ์ง€ ์•Š๊ณ , MCT๋ผ ํ•˜๊ธฐ์—” ์„ธํฌ์งˆ์˜ ์–‘์ด ์ ๋‹ค.
    • Histiocyte โ†’ ๋ฐฐ์ œ ๊ฐ€๋Šฅ.
    • Round cell ํ˜•ํƒœ๋งŒ ๋ณด๊ณ  lymphoma๋ผ๊ณ  ๊ตฌ๋ถ„ํ•˜๋Š” ๊ฒƒ๊นŒ์ง€๋Š” ๋ฐ”๋ผ์ง€ ์•Š๋Š”๋‹ค..
  • Stage๋Š” ๋†’์€ ํŽธ์— ์†ํ•จ.